Skin Booster vs Dermal Filler | Differences, Uses, and Results

The core difference between Skin Boosters and Fillers lies in skin quality improvement and contour shaping. Skin boosters are typically injected into the dermis at a depth of about 1-2 mm, aiming for deep hydration of the entire face, smoothing fine lines, and brightening the complexion, with effects generally lasting 6 to 9 months. Conversely, fillers use high-cross-linked hyaluronic acid injected into deeper subcutaneous tissues or onto the periosteum. They are specifically used for filling local depressions (such as nasolabial folds) and three-dimensional shaping (such as lip enhancement and chin augmentation). They provide strong support, and effects can last as long as 12 to 18 months.

Differences

Skin Boosters utilize non-cross-linked HA or HA with a cross-linking degree lower than 1% (concentrations usually between 15-24 mg/ml). Like a thin liquid, doctors use 30G microneedles to inject it into the superficial dermis at a depth of 1-2 mm, injecting about 2-3 ml per session to improve skin hydration. Dermal Fillers use cross-linked HA (with added BDDE cross-linking agent), which appears as a viscous gel with a high elastic modulus. It is injected into the subcutaneous fat pads or above the periosteum (at depths of 4-10 mm or more), providing physical support. A single injection of 1-5 ml can reshape the jawline or apple cheek contours.

Physical Form

In its natural state, hyaluronic acid molecules present a linear single-chain structure with an extremely short half-life, usually being completely degraded by hyaluronidase in the human body within 24 to 48 hours. To extend the duration of the material in the body, European and American pharmaceutical companies introduced BDDE (1,4-butanediol diglycidyl ether) chemical cross-linking technology. The cross-linking process physically binds the dispersed single chains to form a three-dimensional network structure. The appearance and form of the material undergo a physical phase change depending on the degree of cross-linking. In dermal filler manufacturing workshops, the cross-linking degree of HA is typically set in the 4% to 12% range. A high degree of cross-linking causes the fluid to behave as a high-viscosity gel with a high elastic modulus (G’ value). The G’ value quantifies the gel’s ability to resist external deformation; for example, the G’ value of Juvederm Voluma reaches 274 Pa, and it looks like a firm, transparent jelly. High G’ value gels are less likely to undergo physical displacement when squeezed by facial muscles. Cross-linked filler gels are mechanically cut into particles of different sizes, forming single-phase or double-phase properties in rheology:

• Biphasic gels contain HA particles of specific diameters, such as Restylane Lyft with particle sizes of 800 to 1000 microns.
• Monophasic gels have a uniform and smooth paste texture, containing no independent particles visible to the naked eye.
• The larger the particles, the greater the mechanical extrusion force required during operation.
• High cohesivity ensures the gel remains in a bolus shape under the skin and does not leak into surrounding tissues.

A large number of skin booster products use non-cross-linked HA or HA with a cross-linking degree lower than 1%, with a form close to pure water or a highly fluid serum. Taking Profhilo as an example, the product uses NAHYCO patented thermal cross-linking technology to avoid chemical reagents, combining 32 mg of high-molecular-weight HA and 32 mg of low-molecular-weight HA in a 2 ml. The liquid form gives skin boosters an extremely high viscous modulus (G” value) and extensibility. After the liquid is pushed into the dermis, it does not form gathered lumps like jelly-like fillers. HA molecules can rapidly diffuse outward along the dermal tissue gaps within a radius of 2 to 4 cm. Low cohesivity fluid behavior allows the material to spread evenly across the superficial subcutaneous network like a sponge absorbing water; each gram of HA can bind water molecules 1000 times its own weight. Rheological parameters set the specific physical state of the liquid inside the as seen by the doctor clinically.

Fluids with different viscosities require completely different mechanical extrusion forces. Thick, high G’ fillers typically require 15 to 20 Newtons of thrust and must be used with larger 27G or 25G. Forcibly injecting with a fine will cause the cross-linked chains inside the gel to be damaged by mechanical shear force. Skin boosters have a liquid thrust of less than 5 Newtons and can easily pass through extremely fine 32G or even 34G microneedles. The outer diameter of a 34G microneedle is only 0.2 mm, which significantly reduces the damage rate of tissue capillaries during epidermal puncture. The cross-linking nodes in fillers are dense, making it extremely difficult for water molecules and enzymes to completely penetrate the three-dimensional internal structure of the gel. Hyaluronidase can only strip and degrade the gel bolus layer by layer from the outer surface area. A 1 ml high-cross-linked gel bolus typically takes 9 to 18 months to naturally degrade completely under the skin. After liquid non-cross-linked HA is injected into the dermis, it quickly spreads in a single-molecule form across the tissue network. The vast contact area allows endogenous hyaluronidase to easily wrap around the entire HA molecular chain. After 15 mg/ml of non-cross-linked liquid is injected into the superficial dermis, it is usually completely hydrolyzed by enzymes within 14 to 28 days, subsequently entering the capillary lymphatic vessels to be metabolized and excreted via the circulatory system.

Effect Manifestation

High G’ value cross-linked hyaluronic acid gel injected into deep subcutaneous fat pads relies on physical space-occupying to prop up the overlying soft tissue. Taking zygomatic contouring at the apple cheek as an example, injecting 1.2 ml of Voluma gel on one side can create an average immediate tissue protrusion of 3 to 4 mm in the Z-axis direction. The moment the doctor pulls out the 27G blunt, the shadow in the specific facial depression is declared eliminated. The immediate volume compensation of fillers shows clear millimeter-level morphological displacement in different anatomical areas:

• The height of the vermilion border of the lips increases by 1.5-2.0 mm
• The drooping angle of the jawline folds upward and tightens by about 15 degrees
• The depth of skin folds in the nasolabial folds decreases by 2-3 mm
• The mental protuberance (chin) extends forward by 4-6 mm
• The depressed area of the temple shifts outward by 2-5 mm

After skin boosters are injected into the superficial dermis, besides dense marks and slight mosquito-bite-like wheals, there is no change in skeletal contours. The refractive index of non-cross-linked hyaluronic acid liquid is similar to that of dermal tissue fluid, and it takes time to initiate biochemical reactions at the cellular level. Within the first 48 hours after 2 ml of Profhilo liquid is injected, it diffuses in a network structure under the skin and binds water molecules 1000 times its own weight. The transepidermal water loss (TEWL) begins to drop by about 20% on the 14th day after the intervention. After the HA molecular receptors (CD44) in the dermis are activated, the synthesis of Type I and Type III collagen peaks on the 28th day. By the 4th week after the first intervention, patients observe an increase in light reflectivity in the forehead and cheek areas by about 30%. The depth of facial reticular fine lines shows an average shallowing of 15% to 22% under VISIA skin analysis. The short-term tissue hydration of non-cross-linked liquids translates into multi-dimensional texture data optimization at the skin surface:

• Stratum corneum water content increases by 40% to 55%
• Dermal thickness increases by 0.1-0.2 mm
• Visual pore diameter shrinks by about 10%
• Erythema Index drops by 5%-8%
• Overall skin elastic modulus increases by 25%

The network structure formed by the cross-linker BDDE effectively resists early degradation by endogenous hyaluronidase. In high-hardness HA gel injected deep into the chin, MRI images at 12 months still show 65% to 70% of the initial volume retained. The 3D support usually only shows visible collapse 18 to 24 months after the intervention. Thin liquid HA molecules are completely decomposed and metabolized by enzymes in the body within 28 days. Skin boosters rely on two or three consecutive injections spaced four weeks apart to maintain the extracellular matrix in a highly metabolic state. After completing a standard course, the high hydration state of the skin and the newborn collagen network last for about 6 to 9 months. When the patient notices the reappearance of dry flaking on the cheeks or a loss of morning radiance, the dermal water content has returned to the baseline data before the initial consultation. In some European and American dermatological clinical practices, doctors stack the physical effects of two materials in a single visit. First, 3 ml of high-cross-linked gel is used to build a rigid support frame at the zygomatic bone to restore facial high and low point differences. Subsequently, 2 ml of purified non-cross-linked HA liquid is applied for a 5-point BAP injection spread in the superficial cheek area. Three-dimensional structural support and hydrated surface reflection overlap at the physical level within the same treatment cycle. Superficial hydration smoothes fine surface lines exposed by the stretching of deep soft tissues.

Target Population

As patients pass the age of 35, deep mid-facial fat pads undergo physiological atrophy at an average rate of 1.5 ml per year. The absolute reduction in fat volume causes the overlying skin to lose physical support, resulting in a vertical displacement of 2 to 4 mm toward gravity. CT scan data shows that the maxillary bone angle in women over 40 decreases by about 3 degrees every decade. Skeletal recession leads to the orbital aperture expanding by 1 to 2 mm, visually forming tear trough depressions with depths exceeding 3 mm.

“When a patient pushes up the cheek skin with a finger in front of a mirror and a physical protrusion of 3 to 5 mm appears above the zygoma, high G’ value gel is the only anatomical option for reconstructing the 3D facial structure.” — Clinical Guidelines of the American Academy of Dermatology

The anatomical intervention of high-viscosity filler gels precisely matches patients with clear structural aging data:

• Static skin folds in the nasolabial fold area reaching depths of 4 mm or more
• Blurred jawline with a sagging jowl fat compartment thicker than 5 mm
• Imbalanced upper and lower lip ratio, with a vertical red lip height of less than 8 mm
• Chin recession resulting in a 5 to 7 mm loss of length in the lower third of the face
• Obvious shadows in the temple area recessed 2 to 3 mm inward

The quantified drop in epidermal water-locking capacity guides another group of patients toward non-cross-linked skin booster treatment. VISIA skin detector analysis shows that after age 30, the transepidermal water loss (TEWL) of the stratum corneum rises by about 15% annually. The efficiency of moisture synthesis within the dermis cannot keep up with the evaporation rate of the epidermis, resulting in large areas of dryness on the cheeks. The concentration data for endogenous hyaluronic acid at age 40 will drop to about 50% of its peak at age 20. Dermal thickness subsequently thins by about 0.2 mm, and the epidermis, losing moisture support, begins to show reticular creases. 2 ml of purified HA liquid laid down via superficial fine microneedles can reconstruct the microcirculatory environment of dehydrated tissue gaps within 48 hours.

“In the absence of skeletal shadows, when skin surface light reflectivity drops by more than 20% and superficial fine lines of 0.1 to 0.5 mm are visible, the tissue hydration effect of non-cross-linked liquid can maximize the repair of the extracellular matrix.” — European Journal of Aesthetic Medicine

The physical extensibility of thin liquid HA molecules perfectly fits the following target groups showing indicators of decreased dermal quality:

• Pillow marks on the face take more than 45 minutes to recover after waking up in the morning
• Superficial fine lines with a depth of 0.5 mm exist in the periocular and cheek extension zones
• Skin elasticity testers show a tissue rebound rate decrease of more than 20%
• Face and neck skin presents a parchment-like texture with a thickness of less than 1 mm when pinched
• Pores show a visual diameter expansion of 0.2 mm due to the relaxation of surrounding collagen fibers

Age stratification data shows a distinctly different clinical distribution among the recipient populations of the two treatments. The young group aged 18 to 25 constitutes a high-frequency user base for dermal fillers. Anatomical development results in this group lacking 1 to 3 ml of natural skeletal or soft tissue volume in the jawline and lip areas; doctors use high-cross-linked gels for millimeter-level volumetric reshaping. Patients aged 25 to 30 primarily occupy the preventive anti-aging diagnosis list for skin boosters. They usually have no obvious structural displacement, but long-term exposure to UVA rays or screen blue light causes the skin erythema index to rise by 5%. 1.5 ml of non-cross-linked liquid injected every six months maintains a high metabolic rate for fibroblasts. When facing complex aging samples over 50 years old accompanied by severe photoaging and volume loss, European and American doctors usually stack both materials in the same visit. Patients first receive 3 to 4 ml of high-cross-linked gel above the periosteum to establish a rigid support frame. Subsequently, the doctor grid-injects 2 ml of non-cross-linked liquid into the superficial dermis to smooth out over 15% of epidermal micro-creases. Physical filling of deep tissues and chemical hydration of superficial skin result in overlapping data levels for this population. An extremely small number of severely emaciated patients with a BMI lower than 18 are usually excluded from the standard treatment list due to an insufficient anatomical space for liquid in the subcutaneous fat layer, which is less than 2 mm thick.

Uses

Skin boosters use non-cross-linked or micro-cross-linked HA, targeting the dermal layer 1 to 2 mm under the skin, mainly to increase fibroblast activity. Within a standard 28-day cell turnover cycle, they enhance skin hydration (some clinical data shows a water content increase of up to 60%), specifically treating superficial fine lines and photoaging. Fillers use high-cross-linked HA with a high elastic modulus (G’), injected into subcutaneous fat pads or as deep as above the periosteum (at depths of 5 to 10 mm). Used in doses of 1 to 3 ml, they are specifically for replenishing soft tissue volume, supporting gravitational sagging, and reshaping zygomatic and mandibular contours.

Target Tissue Levels

The target plane for non-cross-linked hyaluronic acid injection is located in the reticular dermis, 1.5 to 2.5 mm below the epidermis. Fibroblasts are primarily concentrated in this area. Hyaluronic acid molecules initiate mechanotransduction pathways by specifically binding to CD44 receptors. After free hyaluronic acid molecules enter the dermis, their half-life under the action of hyaluronidase is typically only 12 to 24 hours. Some micro-cross-linking technologies extend the degradation time to about 3 to 4 weeks. The material forms hydrogen bonds with water molecules within the tissue. Doctors generally use the micro-droplet technique, distributing 0.01 to 0.05 ml of liquid hyaluronic acid in a matrix across the entire face. Small papules about 2 to 3 mm in diameter will typically form on the skin surface, arranged at intervals of 0.5 to 1 cm. The viscoelasticity of the dermal extracellular matrix (ECM) changes accordingly. Clinical biopsy sections show that the thickness of the reticular dermis typically increases by about 10% to 15% four weeks after standard treatment. The synthesis rate of precursor substances for Type I and Type III collagen shows a clear quantitative upward adjustment.

• The papillary dermis thickness is about 0.1-0.2 mm, while the reticular layer can be up to 2 mm thick.
• A single full-face micro-droplet injection usually needs to cover 150 to 200 equidistant points.
• 32G or 34G fine are used for piercing the skin, with the insertion inclination angle often set at 10 to 15 degrees.
• Local anesthetic cream containing 5% lidocaine is often applied for about 45 minutes before the operation.

Penetrating the dermis to reach the superficial subcutaneous fat pad at a depth of 3 to 5 mm, the anatomical environment undergoes a physical change. The loose structure of the superficial fatty fibrous septa cannot provide sufficient rigid support. At this plane, hyaluronic acid fillers with a low elastic modulus (G’ value between 100-200 Pa) are used for soft tissue expansion. In the perioral area, due to frequent contractions of the orbicularis oris, doctors choose materials with high cohesivity, applying extremely small thrusts of 0.1 ml linearly along the submucosa or superficial subcutaneous tissue to prevent material displacement.

European and American anatomical studies show that after middle age, the facial skeletal volume in Caucasians undergoes about 5% volume loss, particularly bone resorption at the pyriform aperture margin of the maxilla and the mandibular angle. High-cross-linked macromolecular fillers (G’ value greater than 500 Pa) must be injected onto the hard structural surfaces deep within the face. The material is placed in deep gaps 5 to 10 mm or more from the skin surface. Bolus injection is the standard operation at this level. The doctor inserts the vertically until it touches the periosteum, pulling back the plunger for 5 to 10 seconds to confirm it hasn’t entered a blood vessel. Hyaluronic acid boluses are pushed in a conical shape over the periosteum in volumes of 0.2 to 0.3 ml at a time. The hard boluses simulate skeletal protrusions, physically pushing up sagging deep fat pads (such as the SOOF). Hyaluronic acid injected deep does not slide with facial expression muscles. Since the vascular distribution of deep tissues is relatively fixed and there are fewer nerve endings, the patient’s pain at this level is usually lower than that of intradermal injection. High G’ value materials at the supraperiosteal level can resist thousands of Pascals of pressure from masticatory and expression muscles.

• The sub-orbicularis oculi fat (SOOF) is located above the zygoma, and its thickness decreases by 1-2 mm with aging.
• Deep injection commonly uses 22G or 25G to avoid the facial and supratrochlear arteries.
• The degradation cycle of hyaluronic acid in deep fat pads often lasts 12 to 18 months.
• A single-side zygomatic volume enhancement usually requires injecting 0.5 to 1.5 ml of high-cross-linked material.

Skin Booster Application

In European and American clinics, non-cross-linked hyaluronic acid injections account for nearly 40% of facial procedures. The photo-damaged dermis is the primary treatment target, especially among Caucasians with Fitzpatrick skin types I to III. High-intensity UVA rays penetrate the epidermis, causing more than 70% of collagen fibers in the reticular dermis to break. Practitioners typically choose hyaluronic acid gels with concentrations of 12 mg/ml to 20 mg/ml. The average molecular weight of free-state hyaluronic acid molecules is controlled by pharmaceutical factories between 500 to 1000 kDa. A standard single full-face procedure typically consumes 2 to 3 ml of liquid material, covering the skin surface via micro-droplet injection. Natural hyaluronic acid entering the tissue will be degraded by hyaluronidase in the body within 24 to 48 hours. Laboratories introduced less than 1% BDDE (1,4-butanediol diglycidyl ether) chemical bonds for micro-cross-linking treatment. The polymerized macromolecular network structure extends the half-life of the material under the skin to 21 to 28 days.

• The single-point injection volume in the forehead area is strictly set to 0.01 to 0.02 ml.
• The outer cheek injection points are arranged in a grid with 1 to 1.5 cm spacing.
• The tip insertion depth must remain in the papillary dermis at 1.5 mm.
• The basic full-face course includes 3 procedures, each 4 weeks apart.

Outside the facial area, the neck skin is highly prone to dryness and horizontal creases because its sebaceous gland density is only one-third of the face’s. European clinical protocols favor the BAP (Bio Aesthetic Points) injection technique. Doctors mark 10 specific anatomical safety points on the neck, avoiding the anterior jugular veins and thyroid cartilage. The operator accurately injects 0.2 ml of mixed-molecular-weight hyaluronic acid into the deep dermis of each point. The material has extremely high fluidity and tissue extension coefficients, and can automatically diffuse over an area of about 4 square cm above the subcutaneous fascia within 24 hours after injection. The décolletage area will form V-shaped sleep lines as deep as 2 mm under side-sleeping pressure and sun exposure. The dermal thickness in this area is less than 1 mm, and micro-droplet injections easily leave raised papules for several weeks. Doctors will switch to a 25G or 27G with a length of 38 mm. The is inserted parallel from a single entry point 2 cm below the clavicle. Using the fanning technique, 1.5 to 2 ml of low-viscosity hyaluronic acid is laid evenly in the superficial subcutaneous tissue. Patients’ Corneometer readings within 2 weeks after the procedure typically increase by 30% to 45%.

• Chest fan injection usually covers 3 to 4 radial channels.
• The single thrust speed is controlled at 0.1 ml/sec to reduce the feeling of tissue tearing.
• After the procedure, patients are advised to wear silicone chest patches for at least 7 days to smooth the epidermis.

The dermis on the back of the hands thins by about 1% to 2% annually with natural aging. After subcutaneous fat tissue is lost, the dorsal venous network and extensor tendons become visually prominent. The vascular path on the back of the hand is complex, and the bruising rate of traditional sharp-multi-point injection is as high as 60%. Standard operating procedures require injecting 0.1 ml of lidocaine with 1:100,000 epinephrine 1 cm above the wrist for local anesthesia and vessel constriction. Then, a 22G large-caliber is used to pass through the deep dermis. The operator injects 1 to 1.5 ml of micro-cross-linked hyaluronic acid into each hand back. The material is placed in the subaponeurotic space above the extensor tendons and superficial fascia. The doctor will immediately perform 3 to 5 minutes of high-frequency circular massage. External pressure causes the liquid hyaluronic acid to evenly cover an area of about 40 square cm on the back of the hand, increasing the thickness and light reflectivity of the subcutaneous tissue, and masking the blue venous network below.

Dermal Filler Application

Pharmaceutical factories mix free-state hyaluronic acid with 6% to 8% BDDE cross-linker in a sterile reactor. The polymer chain segments react at a constant 60 degrees Celsius for 24 hours, forming a solid gel with a 3D network structure. The elastic modulus (G’ value) of the polymer is typically calibrated between 300 to 800 Pascals. Physical properties of high deformation resistance require it to be placed in deep anatomical gaps 3 to 10 mm under the skin.

• Macromolecular particle diameters range from 800 to 1200 microns.
• Materials with a cross-linking degree higher than 9% are used for supraperiosteal injection.
• A standard single capacity is usually 1.0 ml.
• The total degradation cycle in the body is as long as 12 to 24 months.

Bone loss in the zygomatic area typically occurs at a rate of about 0.5 cubic cm per year after age 35. The sub-orbicularis oculi fat (SOOF) subsequently undergoes a physical displacement of about 2 to 4 mm toward the inner bottom. The mid-face flattening phenomenon is particularly significant visually in Caucasian women. The doctor uses a 27G sharp or 22G blunt to enter vertically at the highest point of the zygomatic arch. The tip penetrates the epidermis, dermis, subcutaneous fat, and muscle layers, eventually reaching the hard periosteal surface at a depth of 7 to 9 mm. The operator pushes 0.5 to 1.5 ml of high G’ value filler material above the periosteum on one side.

The supraperiosteal bolus method has a single dose strictly limited to 0.2 to 0.3 ml. The semi-solid hyaluronic acid bolus generates an upward thrust of up to 500 Pascals in the deep layer.

Facial anatomical structures extend downward, and bone resorption at the mandibular angle results in an average reduction in jawline clarity of over 20%. The distance from the anterior border of the masseter to the mental tubercle shortens. The sagging platysma pulls down the subcutaneous soft tissue, forming a double chin with a thickness of 2 to 3 cm. Mandibular contour reshaping requires using macromolecular gel with a 20 mg/ml concentration of hyaluronic acid. The doctor enters along the 1.5 cm anatomical safety line of the lower mandibular border. A 50 mm long 25G is usually used for deep subcutaneous linear threading. Vertical extension in the chin area requires extremely high material cohesivity. The enters at an inclination of about 30 degrees above the mental protuberance. Usually, 1.0 to 2.0 ml of material is injected into one side of the chin to increase vertical length and meet the Esthetic line (E-line) standard.

• Mandibular angle injection often uses 0.5 ml with a fanning technique.
• The resistance when the advances in the subcutaneous fat layer is lower than 0.5 Newtons.
• The chin extension amount is usually controlled within the 2 to 5 mm range.
• Bite force in the mandibular area may briefly drop by 5% within 48 hours after the procedure.

Soft tissue volume loss forms static folds as deep as 3 to 5 mm in the perioral area. Nasolabial folds and marionette lines are jointly formed by the breaking of superficial fatty septa and excessive contraction of the levator labii superioris. Superficial physical stretching cannot fill the tissue depressions below. Hyaluronic acid with a medium degree of cross-linking (G’ value between 150 to 300 Pascals) is allocated for the superficial fat layer. The doctor uses a 27G to enter 2 mm from the fold edge. A retrograde linear injection method is used, slowly releasing the gel at a rate of 0.05 ml/sec while withdrawing the.

0.2 ml of material needs to be injected at the alar base depression, with the injection depth reaching the pyriform aperture margin at 5 mm. The operator avoids the main trunk branches of the facial artery, which are only 2 to 3 mm from the skin surface.

The orbicularis oris muscle contracts over 100,000 times a day, generating extremely high shear stress on the implant. Traditional hard gels easily displace under the mucosa or form nodules with diameters of 1 to 2 mm. European and American doctors often choose custom lip fillers with low elastic modulus and high extensibility. The entry point is chosen 1 mm outside the vermilion border. Usually, a 30G ultra-fine is used to distribute micro-droplets of 0.02 ml in the superficial layer 1 to 2 mm under the mucosa. Caucasian patients’ preference for the golden volume ratio of the upper and lower lips is typically 1:1 or 1:1.6. The hyaluronic acid consumption for a single lip enhancement surgery is strictly limited to between 0.5 to 1.0 ml.

Results

Skin boosters (such as Restylane Skinboosters) take 2-4 weeks to work. Clinical data shows they can increase dermal hydration by about 40%, with effects lasting 6-9 months, focusing on improving superficial fine lines and skin reflectivity. Dermal fillers (such as Juvederm Voluma) provide immediate volume replenishment. Utilizing cross-linked hyaluronic acid with G’ values between 100-800 Pa, they directly elevate the zygoma or improve deep nasolabial folds. Tissue swelling subsides to a stable state within 14 days post-injection, and the volume maintenance period is 12-24 months.

Visual Changes

After injecting skin boosters, the facial optical reflection pattern is the first to undergo a physical change. Diffuse reflection caused by moisture loss in the stratum corneum gradually turns into specular reflection similar to a glass surface. Under indoor natural light, the area of the reflection bands on the zygoma and the nasal bridge typically expands by about 1.5 to 2 cm. After a single 2 ml dose of non-cross-linked hyaluronic acid at 20 mg/ml is evenly distributed in the dermal mesoderm, it can bind a large amount of free water molecules. Ultrasound skin measurements show that in the fourth week after treatment, the epidermal thickness increases by an average of 0.03 to 0.05 mm. Follow-up records from high-resolution skin microscopy indicate that after completing a basic course of three injections (each four weeks apart), the number of static fine lines can drop by 30% to 45% due to the re-filling of the collagen fiber network. For the visual improvement of pore appearance, micro-cross-linked products show a clear astringent effect. Hyaluronic acid droplets injected into the papillary dermis act as micro-reservoirs, increasing the hydrostatic pressure of the tissue around the follicles and physically squeezing the open pore walls inward.

• The absolute area of pores under VISIA detection decreases by an average of 15%
• The skin roughness score in the forehead area drops by about 1.2 grades
• The previously visible uneven pigmentation around the mouth fades
• The cheek erythema index (Erythema) in a bare-faced state decreases

Observing the overall skin tone with the naked eye, the stratum corneum, which previously had a grayish-yellow tone, presents a uniform transparency. Mechanical damage from microneedles weakly stimulates the capillary network, and local microcirculation blood flow increases by about 12% within two weeks after treatment, giving the skin a slight rosy visual effect. Unlike skin boosters that improve a 2D plane, dermal fillers redistribute facial highlights and shadows in 3D space. When cross-linked hyaluronic acid containing lidocaine is injected into specific facial anatomical spaces, the soft tissue is immediately physically propped up because the gel itself has an elastic modulus (G’) of 150 to 600 Pa.

• The mandibular angle (Gonion) can be reduced from 130 degrees to a clearer 120 degrees
• The anterior mental point (Pogonion) extends forward by about 3 to 5 mm
• The highest point of the zygoma is lifted and raised 2 to 4 mm toward the outer top
• The nasofrontal angle transition becomes smooth, with the angle approaching the standard 115 to 120 degrees

Spreading 0.5 ml of medium-molecular-weight hyaluronic acid against the periosteum at the tear trough depression causes the dark shadow area originally produced by the height difference to disappear instantly, and the skin surface under the orbit forms a smooth straight line with the apple cheek. For nasolabial folds caused by sagging, doctors do not inject directly at the line; instead, they inject 1 to 2 ml of high-support filler at fixed points above the malar fat pad. Due to the lifting effect, the depth of the depression from the alar base to the corner of the mouth can typically be reduced by 2 to 3 mm, and the mid-face tissue appears more concentrated visually. Injecting 1 ml of macromolecular gel under the chin muscle can not only extend the chin downward and forward but also align the originally recessed lower face with the nose tip and lips to meet the Ricketts Esthetic line. Using 0.55 ml to 1 ml of soft, low-cross-linked filler injected along the vermilion border significantly increases the sharpness of the cupid’s bow and reshapes the upper-to-lower lip thickness ratio to 1:1.6.

Onset and Metabolic Cycle

The half-life of pure, non-cross-linked hyaluronic acid is extremely short, lasting only 12 to 24 hours in human tissue before being decomposed. Different aesthetic products control the degradation rate by adjusting the BDDE (1,4-butanediol diglycidyl ether) cross-linking technology. Skin boosters mostly use formulas in a free state or containing only trace amounts (less than 1%) of cross-linkers. After being injected 0.8 to 1.5 mm into the superficial dermis, the ingredients undergo a slow process of hydration and biological activation. In the first 48 hours after injection, the microneedle trauma triggers a local inflammatory response, platelets release growth factors, and no improvement in skin quality is visible to the naked eye. Entering days 7 to 14, non-cross-linked hyaluronic acid macromolecules complete their moisture capture, with single molecules binding free water. The hydrostatic pressure within the dermal matrix gradually climbs, and fibroblasts are stimulated by mechanical tension. Histological section comparisons show that on days 21 to 28, the synthesis of Type I procollagen increases by about 18% to 25% compared to the baseline, completing a progressive onset cycle. Specific variables affecting the degradation rate of skin booster molecules include:

• Unprotected exposure to UVA for more than 2 hours daily accelerates molecular chain breakage
• Free radicals from long-term smoking shorten the retention period by 15% to 20%
• Frequent high-intensity aerobic exercise increases local microcirculation flow and speeds up metabolism
• The decline in skin’s natural water-holding capacity due to aging

The network structure of a single skin booster session typically starts to show obvious physical collapse in the 4th month. Hyaluronidase cuts along the molecular chains unprotected by cross-linking bonds, and moisture is gradually released and excreted. By the 6th to 9th month, tracking via isotope labeling shows more than 90% of the injected material has been metabolized into water and carbon dioxide. Concentrated gel containing 8% to 12% cross-linking bonds completes its 3D volume occupation within seconds of being pushed above the periosteum or into the subcutaneous fat pad. Due to the material’s high elastic modulus of over 400 Pa, doctors can physically mold it during the first 5 to 10 minutes after injection. Within the first 24 to 72 hours, the high osmotic pressure characteristic of the gel will absorb surrounding tissue fluid, leading to a temporary 10% to 15% over-expansion in the chin or apple cheek area. By the 14th day, osmotic pressure inside and outside the tissue reaches dynamic equilibrium, slight local edema completely subsides, and the filler presents its final stable form. Microscopic examination found that by the 4th to 6th week, fine collagen fibers will intersperse into the edge pores of the hyaluronic acid gel, forming a thin film about 0.1 mm thick.

Macrophages and hyaluronidase preferentially degrade the free HA segments on the surface of the gel bolus; volume loss in the first 6 months is usually less than 15%. Due to huge anatomical differences in muscle activity across facial regions, the degradation time for the same filler can be vastly different. The orbicularis oris performs tens of thousands of chewing and speaking pulls daily; hyaluronic acid injected in the lips will lose about 60% of its volume by the 6th to 8th month. Muscles in the zygomatic or mandibular angle areas are relatively stationary, and since the material is placed directly against the bone, it receives minimal mechanical squeezing. Ultrasound image tracking confirms that 2 ml of macromolecular high-cross-linked product injected into these deep spaces still retains 30% to 40% of its original volume support even after 24 months. If 1.5 ml of filler was initially injected into the nasolabial fold, the original basal support still exists during a follow-up visit in the 12th month. At this time, only a maintenance injection of 0.5 ml of new gel is needed to restore the tissue thickness and surface tension of the area to the perfect state seen 14 days after the first treatment.

Maintenance Duration

The natural half-life of endogenous hyaluronic acid is only 1 to 2 days; about 30% of the free hyaluronic acid in the dermis is automatically metabolized and replaced by the body every day. The retention time of aesthetic injection products in the body depends entirely on the chemical cross-linking network density and the physical anti-degradation barrier given to the material in the lab. A skin booster course typically includes 3 basic injections, each injecting about 2 ml to 3 ml of micro-cross-linked or non-cross-linked hyaluronic acid gel. clinical reports show that after completing the full course, the hydration peak in the dermal mesoderm usually appears at the 8th week. In the subsequent 3rd to 6th months, macrophages and endogenous hyaluronidase slowly degrade the free molecular chains unprotected by BDDE chemical bonds. By the 9th month, dermal thickness under ultrasound imaging basically returns to the initial baseline before treatment. The patient’s lifestyle will significantly intervene in the actual number of maintenance days for skin boosters in the dermis:

• High-intensity cardio training more than 3 times a week speeds up blood flow and shortens the maintenance period by about 15%
• Long-term exposure to UVA rays leads to a 30% increase in dermal matrix degradation enzyme activity
• For patients drinking less than 1.5 liters of water daily, the loss of hydrated radiance is 4 weeks earlier
• Free radicals generated in smokers accelerate the breaking of hyaluronic acid molecular chains

The maintenance cycle for dermal fillers is extended to 12 to 24 months; some extremely hard products using Vycross technology even remain in the body for over 36 months. A cross-linking degree as high as 10% to 12% forms a dense 3D network structure, making it extremely difficult for enzyme molecules to penetrate the gel’s interior. Differences in muscle activity at various anatomical locations cause huge gaps in the degradation rates of the same filler across different facial regions. The table below shows average degradation performance from European and American clinical dermatological follow-up records.

The surface tension of 0.55 ml of low-viscosity gel injected into the lips usually drops by more than 50% by the 6th month, visually appearing as reduced sharpness of the cupid’s bow. 2 ml of high elastic modulus macromolecular filler placed on the mandibular periosteum degrades extremely slowly because it avoids the physical crushing of facial expression muscles. Long-term MRI tracking images confirm that even in the 24th month after injection, the gel bolus on the bone surface only undergoes slight peripheral degradation of about 0.5 mm. European and American anti-aging clinics usually rely on patients’ self-perception and specific visual indicators to decide when to perform supplementary treatment.

• The originally full Ogee curve below the zygoma reappears as flat or slightly sunken
• The shadow depth of the tear trough under the orbit after waking up exceeds 2 mm
• Touching the chin tip, the originally hard prosthetic feel is replaced by the softness of one’s own soft tissue
• The crease of the marionette lines at the corner of the mouth again exceeds 1 cm in length in a neutral expression

The length of the maintenance period is not a simple linear decay; multiple treatments produce a volume stacking effect. After consecutive years of annual 1 ml filler injections at the same anatomical level for two years, a collagen capsule about 0.1 to 0.2 mm thick will form around the tissue, physically delaying the enzymatic reaction. Due to the presence of a residual base, the third-year follow-up injection typically no longer requires the initial 1 ml dose. The doctor only needs to inject 0.3 ml to 0.4 ml of the same product to pull the 3D volume of the area back to the optimal fullness seen two years prior. For skin boosters, a 0.5 ml maintenance injection every half year can stabilize Type I collagen content in the dermis at a level 20% higher than the baseline. Biopsy samples show that skin receiving regular maintenance has a papillary dermis undulating structure about 40% smoother than skin without intervention.